Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback